Der Vaart Sandra D. Van Sells 1,000 Shares of Laboratory Co. of America Holdings (NYSE:LH) Stock

Laboratory Co. of America Holdings (NYSE:LH) EVP Der Vaart Sandra D. Van sold 1,000 shares of Laboratory Co. of America stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $239.42, for a total transaction of $239,420.00. Following the completion of the sale, the executive vice president now owns 2,670 shares in the company, valued at approximately $639,251.40. This trade represents a 27.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Laboratory Co. of America Price Performance

LH opened at $238.73 on Wednesday. Laboratory Co. of America Holdings has a 1 year low of $191.97 and a 1 year high of $247.99. The stock has a 50-day moving average price of $226.67 and a 200-day moving average price of $217.61. The firm has a market cap of $19.97 billion, a PE ratio of 46.18, a P/E/G ratio of 1.97 and a beta of 1.05. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.44 and a quick ratio of 1.30.

Laboratory Co. of America (NYSE:LH) last issued its earnings results on Thursday, October 24th. The medical research company reported $3.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.02. The firm had revenue of $3.28 billion for the quarter, compared to the consensus estimate of $3.26 billion. Laboratory Co. of America had a net margin of 3.43% and a return on equity of 15.27%. The business’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.38 earnings per share. Sell-side analysts predict that Laboratory Co. of America Holdings will post 14.53 earnings per share for the current fiscal year.

Laboratory Co. of America Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Tuesday, November 26th will be given a dividend of $0.72 per share. The ex-dividend date is Tuesday, November 26th. This represents a $2.88 annualized dividend and a dividend yield of 1.21%. Laboratory Co. of America’s dividend payout ratio (DPR) is presently 55.71%.

Analyst Ratings Changes

LH has been the topic of a number of research reports. Truist Financial lifted their target price on shares of Laboratory Co. of America from $255.00 to $275.00 and gave the company a “buy” rating in a research note on Friday, August 2nd. HSBC raised Laboratory Co. of America from a “hold” rating to a “buy” rating in a research report on Wednesday, October 30th. Robert W. Baird increased their target price on Laboratory Co. of America from $282.00 to $289.00 and gave the stock an “outperform” rating in a research report on Friday, October 25th. StockNews.com cut Laboratory Co. of America from a “buy” rating to a “hold” rating in a research note on Friday, October 25th. Finally, Barclays upped their price target on Laboratory Co. of America from $234.00 to $249.00 and gave the stock an “equal weight” rating in a research note on Friday, October 25th. Five investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $255.92.

Institutional Investors Weigh In On Laboratory Co. of America

Large investors have recently bought and sold shares of the business. Industrial Alliance Investment Management Inc. purchased a new stake in Laboratory Co. of America during the 2nd quarter valued at $27,000. SouthState Corp purchased a new stake in Laboratory Co. of America during the third quarter valued at $28,000. Horizon Bancorp Inc. IN purchased a new stake in Laboratory Co. of America during the third quarter valued at $29,000. Pathway Financial Advisers LLC bought a new position in Laboratory Co. of America in the first quarter valued at about $30,000. Finally, Innealta Capital LLC purchased a new position in Laboratory Co. of America in the second quarter worth about $32,000. 95.94% of the stock is currently owned by institutional investors.

About Laboratory Co. of America

Labcorp Holdings Inc provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests.